These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Retrospective comparison of maternal vs. HPA-matched donor platelets for treatment of fetal alloimmune thrombocytopenia. Giers G, Wenzel F, Fischer J, Stockschläder M, Riethmacher R, Lorenz H, Tutschek B. Vox Sang; 2010 Apr; 98(3 Pt 2):423-30. PubMed ID: 19874573 [Abstract] [Full Text] [Related]
4. [Intravenous human immunoglobulin treatment for neonatal alloimmune thrombocytopenia due to anti-HPA-5b with severe previous history]. Moncharmont P, Vignal M, Merieux Y, Rigal D. Arch Pediatr; 2007 Sep; 14(9):1094-6. PubMed ID: 17590318 [Abstract] [Full Text] [Related]
8. The management of alloimmune neonatal thrombocytopenia. Blanchette VS, Johnson J, Rand M. Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):365-90. PubMed ID: 11030040 [Abstract] [Full Text] [Related]
9. Neonatal alloimmune thrombocytopenia due to anti-P1A1 (anti-HPA-1a): importance of paternal and fetal platelet typing for assessment of fetal risk. Lipitz S, Ryan G, Murphy MF, Robson SC, Haeusler MC, Metcalfe P, Kelsey H, Rodeck CH. Prenat Diagn; 1992 Nov; 12(11):955-8. PubMed ID: 1494549 [Abstract] [Full Text] [Related]
10. Frequencies of maternal platelet alloantibodies and autoantibodies in suspected fetal/neonatal alloimmune thrombocytopenia, with emphasis on human platelet antigen-15 alloimmunization. Mandelbaum M, Koren D, Eichelberger B, Auerbach L, Panzer S. Vox Sang; 2005 Jul; 89(1):39-43. PubMed ID: 15938738 [Abstract] [Full Text] [Related]